List of Tables
    Table 1. Herpes Zoste Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Herpes Zoste Drug Market Trends
    Table 3. Herpes Zoste Drug Market Drivers
    Table 4. Herpes Zoste Drug Market Challenges
    Table 5. Herpes Zoste Drug Market Restraints
    Table 6. Global Herpes Zoste Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Herpes Zoste Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Herpes Zoste Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Herpes Zoste Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Herpes Zoste Drug Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Herpes Zoste Drug Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Herpes Zoste Drug Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Herpes Zoste Drug Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Herpes Zoste Drug Sales Share by Manufacturer, 2017-2022
    Table 15. Global Herpes Zoste Drug Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Herpes Zoste Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Herpes Zoste Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Zoste Drug as of 2021)
    Table 18. Top Players of Herpes Zoste Drug in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Herpes Zoste Drug Product Type
    Table 20. Date of International Manufacturers Enter into Herpes Zoste Drug Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Herpes Zoste Drug Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Herpes Zoste Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Herpes Zoste Drug Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Herpes Zoste Drug Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Herpes Zoste Drug Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Herpes Zoste Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Herpes Zoste Drug Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Herpes Zoste Drug Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Herpes Zoste Drug Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Herpes Zoste Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Herpes Zoste Drug Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Herpes Zoste Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Herpes Zoste Drug Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Herpes Zoste Drug Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Herpes Zoste Drug Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Herpes Zoste Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Herpes Zoste Drug Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Herpes Zoste Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Herpes Zoste Drug Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Herpes Zoste Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Astellas Pharma Inc. Corporation Information
    Table 43. Astellas Pharma Inc. Description and Business Overview
    Table 44. Astellas Pharma Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Astellas Pharma Inc. Herpes Zoste Drug Product
    Table 46. Astellas Pharma Inc. Recent Development
    Table 47. Beijing Minhai Biotechnology Co., Ltd Corporation Information
    Table 48. Beijing Minhai Biotechnology Co., Ltd Description and Business Overview
    Table 49. Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Beijing Minhai Biotechnology Co., Ltd Product
    Table 51. Beijing Minhai Biotechnology Co., Ltd Recent Development
    Table 52. ContraVir Pharmaceuticals, Inc. Corporation Information
    Table 53. ContraVir Pharmaceuticals, Inc. Description and Business Overview
    Table 54. ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. ContraVir Pharmaceuticals, Inc. Product
    Table 56. ContraVir Pharmaceuticals, Inc. Recent Development
    Table 57. Epiphany Biosciences, Inc. Corporation Information
    Table 58. Epiphany Biosciences, Inc. Description and Business Overview
    Table 59. Epiphany Biosciences, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Epiphany Biosciences, Inc. Product
    Table 61. Epiphany Biosciences, Inc. Recent Development
    Table 62. Foamix Pharmaceuticals Ltd. Corporation Information
    Table 63. Foamix Pharmaceuticals Ltd. Description and Business Overview
    Table 64. Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Foamix Pharmaceuticals Ltd. Product
    Table 66. Foamix Pharmaceuticals Ltd. Recent Development
    Table 67. GeneOne Life Science, Inc. Corporation Information
    Table 68. GeneOne Life Science, Inc. Description and Business Overview
    Table 69. GeneOne Life Science, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. GeneOne Life Science, Inc. Product
    Table 71. GeneOne Life Science, Inc. Recent Development
    Table 72. GlaxoSmithKline Plc Corporation Information
    Table 73. GlaxoSmithKline Plc Description and Business Overview
    Table 74. GlaxoSmithKline Plc Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. GlaxoSmithKline Plc Product
    Table 76. GlaxoSmithKline Plc Recent Development
    Table 77. Merck & Co., Inc. Corporation Information
    Table 78. Merck & Co., Inc. Description and Business Overview
    Table 79. Merck & Co., Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. Merck & Co., Inc. Product
    Table 81. Merck & Co., Inc. Recent Development
    Table 82. NAL Pharmaceuticals Ltd. Corporation Information
    Table 83. NAL Pharmaceuticals Ltd. Description and Business Overview
    Table 84. NAL Pharmaceuticals Ltd. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. NAL Pharmaceuticals Ltd. Product
    Table 86. NAL Pharmaceuticals Ltd. Recent Development
    Table 87. ReceptoPharm, Inc. Corporation Information
    Table 88. ReceptoPharm, Inc. Description and Business Overview
    Table 89. ReceptoPharm, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. ReceptoPharm, Inc. Product
    Table 91. ReceptoPharm, Inc. Recent Development
    Table 92. TSRL, Inc. Corporation Information
    Table 93. TSRL, Inc. Description and Business Overview
    Table 94. TSRL, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. TSRL, Inc. Product
    Table 96. TSRL, Inc. Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Herpes Zoste Drug Customers List
    Table 100. Herpes Zoste Drug Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Herpes Zoste Drug Product Picture
    Figure 2. Global Herpes Zoste Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Herpes Zoste Drug Market Size 2017-2028 (US$ Million)
    Figure 4. Global Herpes Zoste Drug Sales 2017-2028 (K Pcs)
    Figure 5. United States Herpes Zoste Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Herpes Zoste Drug Market Size 2017-2028 (US$ Million)
    Figure 7. United States Herpes Zoste Drug Sales 2017-2028 (K Pcs)
    Figure 8. United States Herpes Zoste Drug Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Herpes Zoste Drug Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Herpes Zoste Drug Report Years Considered
    Figure 11. Product Picture of Acyclovir
    Figure 12. Product Picture of Amenamevir
    Figure 13. Product Picture of FV-100
    Figure 14. Product Picture of GLS-5100
    Figure 15. Product Picture of GSK-1437173A
    Figure 16. Product Picture of NAL-3221
    Figure 17. Product Picture of Others
    Figure 18. Global Herpes Zoste Drug Market Share by Type in 2022 & 2028
    Figure 19. Global Herpes Zoste Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 20. Global Herpes Zoste Drug Sales Market Share in Value by Type (2017-2028)
    Figure 21. Global Herpes Zoste Drug Sales by Type (2017-2028) & (K Pcs)
    Figure 22. Global Herpes Zoste Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 23. Global Herpes Zoste Drug Price by Type (2017-2028) & (USD/Pcs)
    Figure 24. United States Herpes Zoste Drug Market Share by Type in 2022 & 2028
    Figure 25. United States Herpes Zoste Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 26. United States Herpes Zoste Drug Sales Market Share in Value by Type (2017-2028)
    Figure 27. United States Herpes Zoste Drug Sales by Type (2017-2028) & (K Pcs)
    Figure 28. United States Herpes Zoste Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 29. United States Herpes Zoste Drug Price by Type (2017-2028) & (USD/Pcs)
    Figure 30. Product Picture of Clinic
    Figure 31. Product Picture of Hospital
    Figure 32. Product Picture of Others
    Figure 33. Global Herpes Zoste Drug Market Share by Application in 2022 & 2028
    Figure 34. Global Herpes Zoste Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. Global Herpes Zoste Drug Sales Market Share in Value by Application (2017-2028)
    Figure 36. Global Herpes Zoste Drug Sales by Application (2017-2028) & (K Pcs)
    Figure 37. Global Herpes Zoste Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 38. Global Herpes Zoste Drug Price by Application (2017-2028) & (USD/Pcs)
    Figure 39. United States Herpes Zoste Drug Market Share by Application in 2022 & 2028
    Figure 40. United States Herpes Zoste Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 41. United States Herpes Zoste Drug Sales Market Share in Value by Application (2017-2028)
    Figure 42. United States Herpes Zoste Drug Sales by Application (2017-2028) & (K Pcs)
    Figure 43. United States Herpes Zoste Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 44. United States Herpes Zoste Drug Price by Application (2017-2028) & (USD/Pcs)
    Figure 45. North America Herpes Zoste Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 46. North America Herpes Zoste Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. U.S. Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Canada Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Europe Herpes Zoste Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 50. Europe Herpes Zoste Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 51. Germany Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. France Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.K. Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Italy Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Russia Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Asia-Pacific Herpes Zoste Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 57. Asia-Pacific Herpes Zoste Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 58. China Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Japan Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. South Korea Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. India Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Australia Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Taiwan Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Indonesia Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Thailand Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Malaysia Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Philippines Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Latin America Herpes Zoste Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 69. Latin America Herpes Zoste Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Mexico Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Brazil Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Argentina Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Middle East & Africa Herpes Zoste Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 74. Middle East & Africa Herpes Zoste Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 75. Turkey Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Saudi Arabia Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. U.A.E Herpes Zoste Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 78. Herpes Zoste Drug Value Chain
    Figure 79. Herpes Zoste Drug Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed